iSOFT Wins new e-Prescribing Deal at Harrogate NHS Trust

iSOFTHarrogate and District NHS Foundation Trust is the latest NHS trust to place an order with iSOFT, a CSC company, for its e-prescribing and medicines administration (ePMA) solution to improve medicines management and reduce the risk of drug-related mistakes.

The move is part of the trust's commitment to ensuring safe and effective care at the 367-bed Harrogate District Hospital. The ePMA solution will integrate with the trust's existing IT infrastructure including PAS, laboratory and eDischarge systems to further promote the timely and accurate sharing of medicines related information within the trust and with GPs.

"We are dedicated to making the safety of our patients and the quality of care our highest priority," said Andrew Alldred, Harrogate's director of pharmacy. "With the proliferation of new drugs, many with similar sounding names, prescribing has become a hugely complex task that is fraught with risk. Paper-based medicines systems can no longer be relied on to meet the demanding needs of a modern and clinically complex hospital environment."

"With research suggesting that at least ten percent of medication orders contain errors, costing the NHS in excess of £500 million a year, there has never been a greater need for ePMA solutions to help improve the timeliness, appropriateness and accuracy of the prescribing and administration of medicines," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution has been shown to greatly reduce adverse medication errors and improve the efficiency of healthcare services."

Harrogate is the fourth NHS trust to become an early adopter of iSOFT's ePMA solution after Pennine Acute, Stockport and Leicester. "Harrogate is a welcome addition to the early adopter programme," Stevens said. "The trust has already achieved an impressive range of meaningful clinical engagement and we are looking forward to continuing our strategic relationship to deliver real benefits for the trust’s staff and its patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

iSOFT ePMA is shown to halve adverse medication errors at hospitals in Australia and New Zealand. These errors can prolong a patient's stay, which in turn blocks hospital beds and increases costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

Analyzing Multiple Mammograms Improves B…

A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...